Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates • Top-line COMP005 data for COMP360 phase 3 pivotal program in treatment-resistant depression now expected in second quarter 2025 • COMP006 data will now be announced after 26-week time point, expected in the second half of 2026 • Strategic reorganization to focus all efforts on COMP360 program resulting in reduction of workforce of approximately 30% • Cash position of $207 million • Conference call on October 31 at 8:00 am ...